Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierluigi Russo

Showing results (31-40 of 133) with videos related to

Pageof 14
Sort By:
Clinical Drug Investigation|May 23, 2007
Cost-analysis of relapsing-remitting multiple sclerosis in Italy after the introduction of new disease-modifying agentsPierluigi Russo, Alessandro Capone, Andrea Paolillo, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 28, 2021
Drug Prices and Value of Oncology Drugs in ItalyPierluigi Russo, Andrea Marcellusi, Matteo Zanuzzi, et al.
Cancer Treatment Reviews|March 11, 2023
Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenarioChiara Ciccarese, Alessandro Strusi, Daniela Arduini, et al.
Diabetes, Obesity & Metabolism|April 23, 2017
Intraclass differences in the risk of hospitalization for heart failure among patients with type 2 diabetes initiating a dipeptidyl peptidase-4 inhibitor or a sulphonylurea: Results from the OsMed Health-DB registryGian Paolo Fadini, Stefania Saragoni, Pierluigi Russo, et al.
JMIR Perioperative Medicine|February 19, 2026
Survival Prediction in Patients With Bladder Cancer Undergoing Radical Cystectomy Using a Machine Learning Algorithm: Retrospective Single-Center StudyFrancesco Andrea Causio, Vittorio De Vita, Andrea Nappi, et al.
Journal of Neurology|September 10, 2005
Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosisValentina Tomassini, Andrea Paolillo, Pierluigi Russo, et al.
British Journal of Haematology|July 29, 2022
Management of chronic myeloid leukaemia patients treated with ponatinib in a real-life setting: A retrospective analysis from the monitoring registries of the Italian Medicines Agency (AIFA)Massimo Breccia, Pier Paolo Olimpieri, Simone Celant, et al.
Drugs - Real World Outcomes|December 7, 2024
Determinants of the Financial Impact of Orphan Drugs in Italy: Differences Between Expected and Observed Pharmaceutical ExpenditureFrancesco Saverio Mennini, Americo Cicchetti, Paolo Sciattella, et al.
Urologia Internationalis|February 18, 2021
Synchronous Partial Nephrectomy and Renal Artery Aneurysm Repair in Bilateral Renal Cancers: Case Report and Literature ReviewNazario Foschi, Mauro Ragonese, Pierluigi Russo, et al.
Journal of Neurology|April 15, 2004
The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPAAndrea Paolillo, Maria Cristina Piattella, Patrizia Pantano, et al.
Pageof 14

Showing results (31-40 of 133) with videos related to

Sort By:
Pageof 14
Clinical Drug Investigation|May 23, 2007
Cost-analysis of relapsing-remitting multiple sclerosis in Italy after the introduction of new disease-modifying agentsPierluigi Russo, Alessandro Capone, Andrea Paolillo, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 28, 2021
Drug Prices and Value of Oncology Drugs in ItalyPierluigi Russo, Andrea Marcellusi, Matteo Zanuzzi, et al.
Cancer Treatment Reviews|March 11, 2023
Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenarioChiara Ciccarese, Alessandro Strusi, Daniela Arduini, et al.
Diabetes, Obesity & Metabolism|April 23, 2017
Intraclass differences in the risk of hospitalization for heart failure among patients with type 2 diabetes initiating a dipeptidyl peptidase-4 inhibitor or a sulphonylurea: Results from the OsMed Health-DB registryGian Paolo Fadini, Stefania Saragoni, Pierluigi Russo, et al.
JMIR Perioperative Medicine|February 19, 2026
Survival Prediction in Patients With Bladder Cancer Undergoing Radical Cystectomy Using a Machine Learning Algorithm: Retrospective Single-Center StudyFrancesco Andrea Causio, Vittorio De Vita, Andrea Nappi, et al.
Journal of Neurology|September 10, 2005
Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosisValentina Tomassini, Andrea Paolillo, Pierluigi Russo, et al.
British Journal of Haematology|July 29, 2022
Management of chronic myeloid leukaemia patients treated with ponatinib in a real-life setting: A retrospective analysis from the monitoring registries of the Italian Medicines Agency (AIFA)Massimo Breccia, Pier Paolo Olimpieri, Simone Celant, et al.
Drugs - Real World Outcomes|December 7, 2024
Determinants of the Financial Impact of Orphan Drugs in Italy: Differences Between Expected and Observed Pharmaceutical ExpenditureFrancesco Saverio Mennini, Americo Cicchetti, Paolo Sciattella, et al.
Urologia Internationalis|February 18, 2021
Synchronous Partial Nephrectomy and Renal Artery Aneurysm Repair in Bilateral Renal Cancers: Case Report and Literature ReviewNazario Foschi, Mauro Ragonese, Pierluigi Russo, et al.
Journal of Neurology|April 15, 2004
The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPAAndrea Paolillo, Maria Cristina Piattella, Patrizia Pantano, et al.
Pageof 14